Piezo1 has been confirmed to be associated with prognosis of several cancers, like breast cancer, glioma, and non-small cell lung cancer (Chen et al. 2018; Huang et al. 2019; Li et al. 2015). Here, PIEZO1 is linked to non-small cell lung carcinoma.